Founded in 1985, the University of Pittsburgh Cancer Institute (UPCI) is the only National Cancer Institute (NCI)-designated Comprehensive Cancer Center in western Pennsylvania. With nearly 400 research and clinical faculty members specializing in disciplines ranging from cancer prevention and early detection to novel therapeutic discovery, survivorship, and end of life care, UPCI maintains a broad strategic vision and comprehensive approach to understanding and defeating cancer.

At UPCI, basic researchers collaborate with clinician-scientists to rapidly advance the most promising laboratory studies into novel clinical trials, providing patients with early access to new and innovative treatments both at the Hillman Cancer Center and throughout the network of UPMC CancerCenter sites. Currently, patients have access to hundreds of clinical trials at UPCI and UPMC CancerCenter.

Sustained by the ongoing recruitment of internationally renowned scientists and planned expansion of laboratory and clinical space, UPCI continues to grow and evolve, making vast strides in its quest to significantly reduce the burden of cancer.